Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.

Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, Cao Y, Shujath J, Gawlak S, Eveleigh D, Rowley B, Liu L, Adnane L, Lynch M, Auclair D, Taylor I, Gedrich R, Voznesensky A, Riedl B, Post LE, Bollag G, Trail PA.

Cancer Res. 2004 Oct 1;64(19):7099-109.

2.

Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits.

Idell S, Mazar A, Cines D, Kuo A, Parry G, Gawlak S, Juarez J, Koenig K, Azghani A, Hadden W, McLarty J, Miller E.

Am J Respir Crit Care Med. 2002 Oct 1;166(7):920-6.

PMID:
12359647
3.

A region in domain II of the urokinase receptor required for urokinase binding.

Bdeir K, Kuo A, Mazar A, Sachais BS, Xiao W, Gawlak S, Harris S, Higazi AA, Cines DB.

J Biol Chem. 2000 Sep 15;275(37):28532-8.

4.

Novel interactions between urokinase and its receptor.

Shliom O, Huang M, Sachais B, Kuo A, Weisel JW, Nagaswami C, Nassar T, Bdeir K, Hiss E, Gawlak S, Harris S, Mazar A, Higazi AA.

J Biol Chem. 2000 Aug 11;275(32):24304-12.

6.

Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture.

Francisco JA, Gawlak SL, Miller M, Bathe J, Russell D, Chace D, Mixan B, Zhao L, Fell HP, Siegall CB.

Bioconjug Chem. 1997 Sep-Oct;8(5):708-13.

PMID:
9327135
8.

Molecular, biological, and preliminary structural analysis of recombinant bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica.

Gawlak SL, Neubauer M, Klei HE, Chang CY, Einspahr HM, Siegall CB.

Biochemistry. 1997 Mar 18;36(11):3095-103.

PMID:
9115985
9.

Characterization of ribosome-inactivating proteins isolated from Bryonia dioica and their utility as carcinoma-reactive immunoconjugates.

Siegall CB, Gawlak SL, Chace D, Wolff EA, Mixan B, Marquardt H.

Bioconjug Chem. 1994 Sep-Oct;5(5):423-9.

PMID:
7849072
10.

In vivo activities of acidic fibroblast growth factor-Pseudomonas exotoxin fusion proteins.

Siegall CB, Gawlak SL, Chace DF, Merwin JR, Pastan I.

Bioconjug Chem. 1994 Jan-Feb;5(1):77-83.

PMID:
7515280
11.
12.

BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells.

Friedman PN, McAndrew SJ, Gawlak SL, Chace D, Trail PA, Brown JP, Siegall CB.

Cancer Res. 1993 Jan 15;53(2):334-9.

13.

Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxin.

Siegall CB, Gawlak SL, Chin JJ, Zoeckler ME, Kadow KF, Brown JP, Braslawsky GR.

Bioconjug Chem. 1992 Jul-Aug;3(4):302-7.

PMID:
1390985
14.

Homodimeric forms of bombesin act as potent antagonists of bombesin on Swiss 3T3 cells.

Gawlak SL, Kiener PA, Braslawsky GR, Greenfield RS.

Growth Factors. 1991;5(2):159-70.

PMID:
1662974
15.

Antibody-forming cells in the contralateral and ipsilateral lymph nodes draining the locally immunized supramammary/suprainguinal region.

Yang TJ, Gawlak SL, Ports WC, Daniels WH.

Comp Immunol Microbiol Infect Dis. 1990;13(1):7-12.

PMID:
2182282
16.

Lymphoid organ weights and organ:body weight ratios of growing beagles.

Yang TJ, Gawlak SL.

Lab Anim. 1989 Apr;23(2):143-6.

PMID:
2709793

Supplemental Content

Loading ...
Support Center